Johnson & Johnson said on Tuesday it struck a deal to buy heart pump maker Abiomed Inc. for $16.6 billion in cash, as it looks to boost growth at its medical devices unit after next year’s planned spinoff of its consumer health business.

Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program, including franchising and direct sales to self-insured corporate clients and healthcare insurers.

A 16-year veteran at Digitas Health, Geoff Thorne will focus on enhancing the company’s technology and strategy offerings to solve complex challenges for its biopharmaceutical, medical technology, and wellness clients.